✦ LIBER ✦

Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen

✍ Scribed by M. Freue; M. Kjaer; C. Boni; J. Joliver; F. Jänicke; H.B. Willemse; R.C. Coombes; S. Van Belle; R. Pérez-Carrión; J. Zieschang; P. Ibarra de Palacios; C. Rose

Book ID: 114482600
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 71 KB
Volume: 9
Category: Article
ISSN: 0960-9776
DOI: 10.1054/brst.1999.0118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

69. An open, comparative randomized tria

69. An open, comparative randomized trial comparing formestane vs oral megestrol acetate as second-line therapy in postmenopausal advanced breast cancer patients

✍ C. Rose; M. Freue; M. Kjaer; C. Boni; F. Jänicke; C. Coombes; P.H.B. Willemse; S 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 303 KB

352 An open, comparative randomized tria

352 An open, comparative randomized trial comparing formestane vs oral megestrol acetate as a second-line therapy in postmenopausal advanced breast cancer patients

✍ C. Rose; M. Freue; M. Kjaer; C. Boni; F. Jänicke; C. Coombes; P.H.B. Willemse; S 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Quality of life in postmenopausal patien

Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment

✍ J Bernhard; M Castiglione-Gertsch; S.-F Hsu Schmitz; B Thürlimann; F Cavalli; R 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 119 KB

PP-8-4 An open, comparative randomized t

PP-8-4 An open, comparative randomized trial comparing formestane vs oral megestrol acetate as a second-line therapy in postmenopausal advanced breast cancer patients

✍ C. Rose; M. Freue; M. Kjaer; C. Boni; F. Jänicke; C. Coombes; P.H.B. Willemse; S 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A randomized cross-over trial comparing

A randomized cross-over trial comparing megestrol acetate with tamoxifen as initial hormone therapy for advanced breast cancer in postmenopausal women

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Oral high-dose medroxyprogesterone aceta

Oral high-dose medroxyprogesterone acetate versus tamoxifen: A randomized crossover trial in postmenopausal patients with advanced breast cancer

✍ Hendrik Van Veelen; Pax H. B. Willemse; Tonnis Tjabbes; Marjan J. H. Schweitzer; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB